Compound Monograph
Vanillyl Alcohol
Vanillyl alcohol (4-hydroxy-3-methoxybenzyl alcohol) is the reduced, alcohol member of vanilla's C6-C1 phenolic trio — the redox partner of vanillin and vanillic acid. A mild antioxidant that out-scavenges vanillin in hydrogen-donation assays, it is also a bioactive of the Chinese herb Gastrodia elata and carries the shared 'vanillyl' head group that makes capsaicin a vanilloid — though its own pharmacology is thin and entirely preclinical.
Sources · 4
Where Does It Come From?
Vanillyl Alcohol is a naturally occurring phenolic (benzyl alcohol; guaiacol derivative), found in Vanilla and 3 other sources. It is well tolerated orally (low toxicity).
Concentration
Content by Source
Reported concentrations across the plants that contain vanillyl alcohol — the bar marks the typical level, the line shows the reported range.
Literature figures for varying plant parts and preparations. Read them as a comparative guide, not exact assays.
Vanillyl Alcohol at a Glance
Vanillyl alcohol, or 4-hydroxy-3-methoxybenzyl alcohol, is a simple phenolic benzyl alcohol — the reduced (alcohol) member of vanilla’s C6-C1 phenolic trio, sitting one oxidation step below vanillin and two below vanillic acid. Where vanillin carries an aldehyde and vanillic acid a carboxylic acid, vanillyl alcohol carries a –CH₂OH group on the same guaiacol (4-hydroxy-3-methoxyphenyl) ring 1,
It is a minor constituent of cured vanilla pods (~0.56-0.57% of dry weight), but a more prominent bioactive of the Chinese medicinal rhizome Gastrodia elata (tian ma), and it forms wherever wood lignin degrades — so trace amounts turn up in oak-aged spirits and wine. Its clearest measured property is a mild antioxidant one: in classic hydrogen-donation radical assays it actually out-scavenges vanillin, which is nearly inert there 1,
Two things make this molecule worth a page beyond “vanilla’s third phenol.” It is the structural “vanillyl” head group shared with capsaicin and gingerol — the moiety that defines the vanilloids and their action at the TRPV1 receptor 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →. And its own pharmacology, while real, is thin and entirely preclinical: a scatter of single cell-and-rodent studies (anticonvulsant, neuroprotective, anti-inflammatory, vasorelaxant), no human efficacy data, and a metabolism that has barely been characterised.
The Vanillin Redox Family
Vanillyl alcohol, vanillin and vanillic acid are the same guaiacol ring at three oxidation states — a compact redox ladder that is the key to reading all three pages together:
- Vanillyl alcohol (–CH₂OH) — the reduced alcohol, this molecule.
- Vanillin (–CHO) — the aldehyde in the middle; the aroma molecule and the one carrying the broad researched pharmacology.
- Vanillic acid (–COOH) — the fully oxidised acid; a widespread dietary phenolic acid and vanillin’s main metabolite.
The interconversions are real and bidirectional. Oxidising vanillyl alcohol gives vanillin; oxidising vanillin gives vanillic acid; and microbes run the ladder the other way — a yeast from decaying wood reduces vanillin back to vanillyl alcohol, and the same reduction is the standard laboratory synthesis (see Discovery & Synthesis). In the cured vanilla pod all three accumulate together during curing, at roughly vanillin ≫ vanillyl alcohol > vanillic acid (about 1.5%, 0.57%, and 0.18% of dry weight respectively) 8Reference 8Effects of killing conditions of vanilla (Vanilla planifolia, Andrews) pods during the curing process on aroma composition of pod ethanol extractView study →.
The redox position also predicts the antioxidant contrast that is this molecule’s most distinctive measured trait. In classic radical assays (DPPH, galvinoxyl) that reward simple hydrogen donation, vanillyl alcohol and vanillic acid clearly out-perform vanillin, which is essentially inert there because it scavenges by an unusual self-dimerisation route rather than donating a hydrogen atom 1,
The Vanilloid Head Group
The reason chilli-pepper heat, ginger pungency and vanilla share a receptor is a shared substructure, and vanillyl alcohol is that substructure with a hydroxyl cap. The vanillyl group — the 4-hydroxy-3-methoxybenzyl moiety — is the “head” of the classic vanilloid pharmacophore, the part that anchors capsaicin (8-methyl-N-vanillyl-6-nonenamide) and the gingerols into the capsaicin-binding pocket of the TRPV1 ion channel 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →. Capsaicin is, quite literally, a long fatty tail hung off a vanillyl head.
That structural kinship is not just nomenclature. In a direct comparison of vanilloid analogues, vanillyl alcohol itself activated TRPV1 — dose-dependently raising intracellular calcium, and losing that response when the capsaicin-sensing residues (Y511/S512) were mutated, confirming it engages the same pocket as capsaicin 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →. But shortening the molecule to just the head group costs almost all the potency: vanillyl alcohol is a very weak agonist, needing millimolar concentrations where capsaicin acts at nanomolar ones — roughly a thousand-fold weaker 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →. So the honest framing is structural relative, not functional one: vanillyl alcohol shows why the vanilloid head matters, while demonstrating that the head alone barely works.
What It's Used For
Beyond its antioxidant chemistry, vanillyl alcohol’s pharmacology is a thin preclinical scatter — a handful of single cell-and-rodent studies, several traceable to its role in the anticonvulsant herb Gastrodia elata, with no human efficacy data anywhere.
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Every row rests on isolate cell/animal work — most on a single study — with no human trials, so scores stay low by design; read the per-row basis.
The best-characterised property, and the one where the molecule genuinely stands out from vanillin. In a comparative panel of four vanillin derivatives, vanillyl alcohol and vanillic acid were “clearly superior” to vanillin and ethyl vanillin in the model radical assays — the DPPH and galvinoxyl systems that reward simple hydrogen-atom donation — precisely because vanillin scavenges those radicals only through an inefficient self-dimerisation route 1,
In the ORAC assay the ranking flips (vanillin and ethyl vanillin lead), so the “better antioxidant” depends entirely on the chemistry of the assay 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivo — comparison of vanillin, vanillyl alcohol, vanillic acid and ethyl vanillinView study →.
This radical-scavenging capacity is invoked as the mechanism behind its anticonvulsant and neuroprotective effects below 2,
Gap: in-vitro assay chemistry of the isolate that diverges sharply by method; no human antioxidant outcome rests on vanillyl alcohol specifically 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivo — comparison of vanillin, vanillyl alcohol, vanillic acid and ethyl vanillinView study →.
The signal tied most directly to traditional use. Vanillyl alcohol is a bioactive of Gastrodia elata (tian ma), a Chinese herb long used for convulsive disorders. In rats with ferric-chloride-induced epileptic seizures, vanillyl alcohol given before the iron injection significantly reduced seizure (“wet-dog shake”) activity at both 100 and 200 mg/kg, and at 200 mg/kg also cut circulating free-radical (chemiluminescence) markers and brain lipid-peroxide levels — the authors concluding its free-radical scavenging underlies the anticonvulsant effect 2Reference 2AnimalAnticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats — animal modelView study →.
Broader Gastrodia pharmacology also attributes a GABA-enhancing contribution to the compound.
Gap: a single isolated-molecule rodent study at high injected doses, in a chemical seizure model — a model, not epilepsy — with no human data 2Reference 2AnimalAnticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats — animal modelView study →.
One cell-model study, again via the Gastrodia connection. In MPP⁺-treated MN9D dopaminergic cells (a Parkinson’s-disease model), vanillyl alcohol improved cell viability, attenuated reactive-oxygen-species accumulation, lowered the pro-apoptotic Bax/Bcl-2 ratio and reduced PARP cleavage — protecting the neurons against toxin-induced apoptosis by relieving oxidative stress 3Reference 3In vitroNeuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells — in vitroView study →.
Gap: a single in-vitro isolate study in one cell line; no in-vivo or human neuroprotection data, and unresolved brain-exposure questions for a small phenol 3Reference 3In vitroNeuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells — in vitroView study →.
A single report bundling three related activities. Vanillyl alcohol showed anti-angiogenic activity in the chick chorioallantoic-membrane (CAM) assay, anti-inflammatory activity in acetic-acid-induced vascular permeability and carrageenan-induced air-pouch models in mice, and anti-nociceptive activity in the acetic-acid writhing test — the authors framing it as a possible contributor to the effects of folk medicines that contain it 4Reference 4AnimalAnti-angiogenic, anti-inflammatory and anti-nociceptive activities of vanillyl alcohol — animal modelView study →.
Gap: one isolate study across several acute rodent/avian screening models, with no defined molecular mechanism and no human data 4Reference 4AnimalAnti-angiogenic, anti-inflammatory and anti-nociceptive activities of vanillyl alcohol — animal modelView study →.
A family effect in which vanillyl alcohol is the weakest member. In isolated porcine coronary and basilar arteries, vanillin, vanillyl alcohol and ethyl vanillin all produced concentration-dependent relaxation of vessels pre-contracted by several agonists, acting by inhibiting L-type Ca²⁺ channels (they blocked contraction to the channel opener Bay K8644 and to Ca²⁺ re-introduction) — but vanillyl alcohol was less potent than vanillin 5Reference 5Vanillin and vanillin analogs relax porcine coronary and basilar arteries by inhibiting L-type Ca²⁺ channels — ex vivoView study →.
Gap: one ex-vivo isolated-vessel study; no in-vivo or human cardiovascular data, and the isolate is the weakest analogue tested 5Reference 5Vanillin and vanillin analogs relax porcine coronary and basilar arteries by inhibiting L-type Ca²⁺ channels — ex vivoView study →.
Structurally central, functionally marginal. As the bare vanillyl head group, vanillyl alcohol activates the capsaicin receptor TRPV1: it dose-dependently raised intracellular calcium and lost that response when the capsaicin-sensing residues Y511/S512 were mutated, confirming it binds the same pocket as capsaicin 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →. But it is a very weak agonist, requiring millimolar concentrations versus capsaicin’s nanomolar ones — about a thousand-fold weaker — because the potency-conferring lipophilic tail is missing 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →.
Gap: an in-vitro receptor-pharmacology study establishing weak agonism only; no physiological or therapeutic TRPV1 effect is demonstrated for the isolate 6Reference 6In vitroThe effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitroView study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Radical scavenging (DPPH / galvinoxyl, hydrogen donation) | high-efficiency H-atom donation — out-scavenges vanillin | antioxidantanticonvulsantneuroprotective |
| Brain lipid peroxidation / circulating free radicals | ↓ seizure-associated oxidative stress | anticonvulsant |
| ROS / Bax-Bcl-2 / PARP apoptosis axis | ↓ ROS, ↓ Bax/Bcl-2, ↓ PARP cleavage → less neuronal apoptosis | neuroprotective |
| GABAergic transmission | enhancement (Gastrodia-attributed) | anticonvulsant |
| L-type Ca²⁺ channels | inhibition → vascular smooth-muscle relaxation (weaker than vanillin) | vasorelaxant |
| TRPV1 (capsaicin pocket, Y511/S512) | weak agonism, ~1,000× less potent than capsaicin | vanilloid activity |
The load-bearing thread is antioxidant / free-radical scavenging — the one property measured robustly, and the mechanism the anticonvulsant and neuroprotective studies both lean on. The vanilloid-receptor and Ca²⁺-channel actions are real but marginal: vanillyl alcohol is the weak relative in both stories.
Pharmacokinetics
Vanillyl alcohol’s human pharmacokinetics are essentially uncharacterised — Cmax, half-life and oral bioavailability of the isolate are not established. What can be said is structural and by analogy: it is a small, moderately lipophilic phenolic benzyl alcohol expected to be metabolised like other simple phenolics, and it sits on a redox ladder that the body and its microbes traverse in both directions, so it can be oxidised toward vanillin and vanillic acid and conjugated (glucuronide/sulfate) for excretion. The efficacy studies above sidestep this gap by using injection (the 100-200 mg/kg anticonvulsant doses) or direct cell exposure 2,
Clinical Trials
There are no controlled human efficacy trials of vanillyl alcohol. The entire evidence base is in-vitro and rodent work on the isolate; human exposure is dietary, as a flavouring.
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| —(none of the isolate) | — | — | Antioxidant, anticonvulsant, neuroprotective, anti-inflammatory/anti-nociceptive, vasorelaxant, TRPV1 |
Last checked: July 2026.
Isolate vs. Plant Studies
The split is clean and worth stating plainly. The entire evidence base is the isolated molecule — vanillyl alcohol in radical assays 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivo — comparison of vanillin, vanillyl alcohol, vanillic acid and ethyl vanillinView study →, injected into seizure-model rats 2Reference 2AnimalAnticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats — animal modelView study →, dosed onto dopaminergic cells 3Reference 3In vitroNeuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells — in vitroView study →, screened in inflammation/angiogenesis models 4Reference 4AnimalAnti-angiogenic, anti-inflammatory and anti-nociceptive activities of vanillyl alcohol — animal modelView study →, and applied to isolated arteries and TRPV1-expressing cells 5,
In its source plants, vanillyl alcohol is always a minor or co-acting component. In vanilla it is one of several curing-derived phenols behind the dominant vanillin, and the whole cured pod is barely studied against the isolate 8Reference 8Effects of killing conditions of vanilla (Vanilla planifolia, Andrews) pods during the curing process on aroma composition of pod ethanol extractView study →. In Gastrodia elata it is one of a group of active phenolics — gastrodin, p-hydroxybenzyl alcohol, vanillyl alcohol — so the herb’s anticonvulsant and neuroprotective reputation cannot be attributed to vanillyl alcohol alone, even though the isolate studies were designed to probe that role 2,
Its Role in Plants
Vanillyl alcohol is not really a product of the living plant. Like the rest of vanilla’s phenolic profile, it appears during post-harvest killing and curing, when the pod’s enzymes and oxidative chemistry transform stored glucosides — it is part of the same phenylpropanoid / C6-C1 pool that yields vanillin and vanillic acid, sitting at the reduced end of that ladder 8Reference 8Effects of killing conditions of vanilla (Vanilla planifolia, Andrews) pods during the curing process on aroma composition of pod ethanol extractView study →. It also arises abiotically and microbially as a lignin-degradation product: guaiacyl lignin breaks down to vanillin, which wood-dwelling microbes can then reduce to vanillyl alcohol, which is why trace amounts accompany vanillin in oak-aged spirits and wine.
In Gastrodia elata, a chlorophyll-free parasitic orchid used in Chinese medicine, vanillyl alcohol is one of the rhizome’s characteristic phenolics alongside gastrodin and p-hydroxybenzyl alcohol — a defence/antioxidant-type phenolic pool rather than a signalling molecule. These are plant-biochemistry roles and should not be read as human pharmacology.
Prevalence in Nature
Vanillyl alcohol is narrowly distributed and usually minor. Its best-quantified occurrence is in cured vanilla pods (Vanilla planifolia), at roughly 0.56-0.57% of dry weight — about a third of the pod’s vanillin and a curing product rather than a constituent of the green pod 8Reference 8Effects of killing conditions of vanilla (Vanilla planifolia, Andrews) pods during the curing process on aroma composition of pod ethanol extractView study →. It is a more prominent bioactive of the rhizome of Gastrodia elata (tian ma), where it sits among the herb’s characteristic phenolics 2,
Major Natural Sources
| Source | Plant part | Reported vanillyl-alcohol content |
|---|---|---|
| Vanilla (Vanilla planifolia) | cured pod | ~0.56-0.57% dry weight 8Reference 8Effects of killing conditions of vanilla (Vanilla planifolia, Andrews) pods during the curing process on aroma composition of pod ethanol extractView study → |
| Gastrodia elata (tian ma) | rhizome | characteristic bioactive phenol; not individually quantified here 2, |
| Oak-aged spirits / wine | — | trace, as a vanillin-reduction / lignin-degradation product |
Only the vanilla figure is quantified in the sources reviewed here; the remaining occurrences are qualitative, and the missing numbers are tracked for a later pass.
Discovery & Synthesis
Vanillyl alcohol entered chemistry as a derivative of vanillin rather than as a headline discovery. Vanillin itself was isolated from vanilla and structurally solved in the mid-nineteenth century, and vanillyl alcohol — its straightforward reduction (alcohol) analogue — has been known since that era of vanilla chemistry; a precise “first isolation” date for the alcohol is not well documented.
Manufacture is by simple reduction of vanillin — classically with sodium borohydride under basic conditions, then acid quench — and the same conversion happens biologically: a yeast (Cystobasidium laryngis) isolated from decaying wood biotransforms vanillin into vanillyl alcohol, one of several microbial routes along the vanillin redox ladder. There is no meaningful plant-extraction industry for the isolate; commercial vanillyl alcohol is a made molecule, produced for use as a flavouring and as a chemical building block (the vanillyl head group is a synthon for capsaicin-type vanilloids).
Patents: not yet researched.
Toxicity & Safety
Vanillyl alcohol carries a low flag. It is a permitted flavouring agent — a simple phenolic benzyl alcohol structurally close to vanillin, cleared for food use as a synthetic flavouring substance and expected to be metabolised rapidly like other simple phenolics, and it is not classified as a carcinogen, mutagen or reproductive toxicant by the major agencies. In the preclinical literature it appears as a protective agent — antioxidant, anticonvulsant, neuroprotective — rather than a toxicant 2,
The honest limits are the usual ones for a molecule with no human safety trials: dedicated repeat-dose, genotoxicity and reproductive packages for the pure isolate are not characterised here, and there are no human drug-interaction studies. Because it is a weak TRPV1 agonist and an L-type-Ca²⁺-channel-inhibiting vasorelaxant 5,
- A food-safe flavouring phenol. A permitted flavouring agent, structurally close to vanillin and metabolised like a simple phenolic; not classed as a carcinogen, mutagen or reproductive toxicant.
- Preclinical studies use it as a protectant. Antioxidant, anticonvulsant and neuroprotective effects — not toxicity — in the rodent and cell literature.
- Safety rests on preclinical and dietary data. No human trials, and no characterised repeat-dose/genotoxicity package for the pure isolate.
- Interactions untested. Theoretical, unquantified additive effect at medicinal quantities given its weak TRPV1 and Ca²⁺-channel activity; not a concern at food levels.
Dosage
There is no established or recommended human dose for isolated vanillyl alcohol. The few efficacy figures are preclinical research doses, not convertible to human self-dosing:
| Application | Form / route (research) | Dose studied |
|---|---|---|
| Anticonvulsant | Vanillyl alcohol, rat (injected) | 100-200 mg/kg before seizure induction 2Reference 2AnimalAnticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats — animal modelView study → |
| Neuroprotective | Vanillyl alcohol, cell model | in-vitro concentrations (MPP⁺-treated MN9D cells) 3Reference 3In vitroNeuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells — in vitroView study → |
| Antioxidant | Vanillyl alcohol, in-vitro assays | assay concentrations (DPPH/galvinoxyl/ORAC) 1Reference 1In vitroAntioxidant properties of ethyl vanillin in vitro and in vivo — comparison of vanillin, vanillyl alcohol, vanillic acid and ethyl vanillinView study → |
Human exposure is dietary and low — as a permitted flavouring and a trace constituent of vanilla and oak-aged drinks — and where the studied route was injection or direct cell exposure, no oral equivalent is meaningful. These are doses studied in research and are not a personal recommendation.
References
- Tai A, Sawano T, Yazama F (2011). Antioxidant properties of ethyl vanillin in vitro and in vivo — comparison of vanillin, vanillyl alcohol, vanillic acid and ethyl vanillin. Bioscience, Biotechnology, and Biochemistry. https://pubmed.ncbi.nlm.nih.gov/22146718/
- Hsieh CL, Chang CH, Chiang SY, et al. (2000). Anticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats — animal model. Life Sciences. https://pubmed.ncbi.nlm.nih.gov/10954052/
- Kim IS, Choi DK, Jung HJ (2011). Neuroprotective effects of vanillyl alcohol in Gastrodia elata Blume through suppression of oxidative stress and anti-apoptotic activity in toxin-induced dopaminergic MN9D cells — in vitro. Molecules. https://pubmed.ncbi.nlm.nih.gov/21705974/
- Jung HJ, Song YS, Lim CJ, Park EH (2008). Anti-angiogenic, anti-inflammatory and anti-nociceptive activities of vanillyl alcohol — animal model. Archives of Pharmacal Research. https://pubmed.ncbi.nlm.nih.gov/18958417/
- Raffai G, Khang G, Vanhoutte PM (2015). Vanillin and vanillin analogs relax porcine coronary and basilar arteries by inhibiting L-type Ca²⁺ channels — ex vivo. Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.114.217935
- Oka Y, Takahashi K, Ohta T (2022). The effects of vanilloid analogues structurally related to capsaicin on the transient receptor potential vanilloid 1 channel — in vitro. Biochemistry and Biophysics Reports. https://pubmed.ncbi.nlm.nih.gov/35280525/
- Tai A, Sawano T, Yazama F, Ito H (2011). Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays — in vitro. Biochimica et Biophysica Acta. https://pubmed.ncbi.nlm.nih.gov/21095222/
- Pardío VT, Mariezcurrena MD, Waliszewski KN, et al. (2009). Effects of killing conditions of vanilla (Vanilla planifolia, Andrews) pods during the curing process on aroma composition of pod ethanol extract. International Journal of Food Science and Technology. https://doi.org/10.1111/j.1365-2621.2009.01944.x
